JP:4882 Stock Latest News
Company AnnouncementsPerseus Proteomics Flags FX Gains, Financing Costs and Asset Impairment in Q2 Results2M ago4882
Company AnnouncementsPerseus Proteomics Narrows Loss as Sales Rise but Withholds Full-Year Outlook2M ago4882
Company AnnouncementsPerseus Proteomics Reports Durable Phase I Follow-Up Results for PPMX-T003 in Polycythemia Vera4M ago4882
Company AnnouncementsPerseus Proteomics Corrects Cash Flow Figures in FY2026 Results4M ago4882
Company AnnouncementsPerseus Proteomics Overhauls Board, Taps New Director to Lead Business Development5M ago4882
Company AnnouncementsPerseus Proteomics Books Subsidy Income but Suffers Asset Impairment in FY20265M ago4882Company AnnouncementsPerseus Proteomics Narrows Losses but Withholds FY2027 Forecast Amid Funding Dependence5M ago4882
Company AnnouncementsPerseus Proteomics Wins AMED Grant to Advance PPMX-T003 for Rare Leukemia7M ago4882
Company AnnouncementsPerseus Proteomics Sets FY2026 Forecast, Stays in Red as Licensing Push Continues7M ago4882
Company AnnouncementsPerseus Proteomics Books Subsidy Income but Suffers Asset Impairment in Q38M ago4882- Company AnnouncementsPerseus Proteomics Narrows Losses but Withholds Full-Year Forecast Amid Ongoing Cash Burn8M ago4882
- Company AnnouncementsPerseus Proteomics Partners with Eurus Therapeutics for Antibody Research11M ago4882
Company AnnouncementsPerseus Proteomics Extends Clinical Trial for ANKL Treatment11M ago4882Company AnnouncementsPerseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges11M ago4882
Company AnnouncementsPerseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs12M ago4882
- Company AnnouncementsPerseus Proteomics Reports Q1 FY2026 Progress and Financial Growth1y ago4882
Company AnnouncementsPerseus Proteomics Reports Q1 Financial Results with Continued Losses1y ago4882
Company AnnouncementsPerseus Proteomics Announces Capital Restructuring to Strengthen Financial Base1y ago4882
Company AnnouncementsPerseus Proteomics Inc. Announces Change in Accounting Auditor1y ago4882
Company AnnouncementsPerseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty1y ago4882Company AnnouncementsPerseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges1y ago4882
